Investing.com··Jeffrey Neal JohnsonBiodefense Boom: Co-Diagnostics Eyes National Security Contracts Amid Ebola Emergency
Co-Diagnostics surges 200%+ as WHO declares Ebola emergency, positioning the company's decentralized manufacturing network as strategic national security asset.
CODXOSURGOVXFDA approvalnational security